Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | EVP, Chief Commercial Officer | June 03, 2026 | June 05, 2026 |
| MASIMO CORPMASI · Entity 39014 | Pres-WW OEM & Global Health | February 26, 2021 | March 02, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date June 03, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,361 |
Reported balance
After 2026-06-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-03 · Sale · Disposed 4,912 · Balance 100,361 F1: On March 4, 2026, Mr. Coleman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Coleman. The shares set forth above were sold pursuant to the 10b5- 1 Plan. |
| Common StockSEC Table I · non-derivative | Direct | 95,450 |
Reported balance
After 2026-06-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-06-04 · Sale · Disposed 4,911 · Balance 95,450 F1: On March 4, 2026, Mr. Coleman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Coleman. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2: Included in this number are 95,450 unvested restricted stock units, 43,897 of which were granted on March 8, 2026 and shall vest through March 8, 2029, and 51,553 of which were granted on May 22, 2025 and shall vest through May 22, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 4, 2026, Mr. Coleman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Coleman. The shares set forth above were sold pursuant to the 10b5- 1 Plan.
F2: Included in this number are 95,450 unvested restricted stock units, 43,897 of which were granted on March 8, 2026 and shall vest through March 8, 2029, and 51,553 of which were granted on May 22, 2025 and shall vest through May 22, 2029.
MASIMO CORP
Report date February 26, 2021 · Filed March 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $250.73 · Expires 2031-02-26 | Direct | 2,637 |
Reported balance
After 2021-02-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-02-26 · Grant · Acquired 2,637 · Balance 2,637 F1: This option was granted on February 26, 2021 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted on February 26, 2021 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 5, 2026 20:17 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 4,911 | $74.13 | $364,052.43 |
DisclosureSEC source: 0001093557-26-000127 · wk-form4_1780690655.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,450 F1 · shares: On March 4, 2026, Mr. Coleman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Coleman. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2 · balance_after: Included in this number are 95,450 unvested restricted stock units, 43,897 of which were granted on March 8, 2026 and shall vest through March 8, 2029, and 51,553 of which were granted on May 22, 2025 and shall vest through May 22, 2029. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:17 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 4,912 | $73.00 | $358,576.00 |
DisclosureSEC source: 0001093557-26-000127 · wk-form4_1780690655.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,361 F1 · shares: On March 4, 2026, Mr. Coleman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Coleman. The shares set forth above were sold pursuant to the 10b5- 1 Plan. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:38 UTC | DEXCOM INC DXCM · Entity 3114 | Tax withholdingCommon Stock | 7,362 | $71.90 | $529,327.80 |
DisclosureSEC source: 0001093557-26-000095 · wk-form4_1779914332.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,273 F1 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. F2 · balance_after: Included in this number are 95,450 unvested restricted stock units, 43,897 of which were granted on March 8, 2026 and shall vest through March 8, 2029, and 51,553 of which were granted on May 22, 2025 and shall vest through May 22, 2029. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 43,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000045 · wk-form4_1773172888.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,635 F1 · shares: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 112,635 unvested RSUs, 43,897 of which were granted on March 8, 2026 and shall vest through March 8, 2029, and 68,738 of which were granted on May 22, 2025 and shall vest through May 22, 2029. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:12 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 68,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000195 · wk-form4_1748376728.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,738 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in four equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:23 UTC | MASIMO CORP MASI · Entity 39014 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 2,637 | $250.73 Strike: $250.73 | $661,175.01 |
DisclosureSEC source: 0000937556-21-000061 · wf-form4_161472017800652.xml · derivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW OEM & Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,637 Underlying: Common Stock · 2,637 shares Expires 2031-02-26 F1 · derivative.exercise_date: This option was granted on February 26, 2021 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:19 UTC | MASIMO CORP MASI · Entity 39014 | GrantCommon Stock | 14,593 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-21-000039 · wf-form4_161420150613849.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW OEM & Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,272 F1 · kind: On March 16, 2018, the Reporting Person was granted performance restricted stock units which vested on February 22, 2021 based on the Issuer's achievement of certain FY2020 pre-established performance objectives. Read SEC document |
| January 02, 2021 Filed Jan 6, 2021 21:14 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionRestricted Stock Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-21-000008 · wf-form4_160996768111214.xml · derivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW OEM & Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU. F2 · derivative.exercise_date: On February 27, 2018, the Reporting Person was granted 10,000 restricted stock units, 20% of which were vested upon grant and 20% of which will vest on the first business day of each fiscal year thereafter. F2 · derivative.expiration_date: On February 27, 2018, the Reporting Person was granted 10,000 restricted stock units, 20% of which were vested upon grant and 20% of which will vest on the first business day of each fiscal year thereafter. Read SEC document |
| January 02, 2021 Filed Jan 6, 2021 21:14 UTC | MASIMO CORP MASI · Entity 39014 | Tax withholdingCommon Stock | 786 | $268.38 | $210,946.68 |
DisclosureSEC source: 0000937556-21-000008 · wf-form4_160996768111214.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW OEM & Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,679 Read SEC document |
| January 02, 2021 Filed Jan 6, 2021 21:14 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-21-000008 · wf-form4_160996768111214.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW OEM & Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:21 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 8,250 | $31.01 Strike: $31.01 | $255,832.50 |
DisclosureSEC source: 0000937556-20-000193 · wf-form4_160936325371355.xml · derivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW OEM & Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 8,250 shares Expires 2025-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on March 20, 2015 and is exercisable as the option vests. The option vested over a 5 year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:21 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 8,250 | $264.02 | $2,178,165.00 |
DisclosureSEC source: 0000937556-20-000193 · wf-form4_160936325371355.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW OEM & Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,465 F1 · kind: The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of November 25, 2020, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:21 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 8,250 | $31.01 | $255,832.50 |
DisclosureSEC source: 0000937556-20-000193 · wf-form4_160936325371355.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW OEM & Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:05 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 1,250 | $31.01 Strike: $31.01 | $38,762.50 |
DisclosureSEC source: 0000937556-20-000139 · wf-form4_159423872074184.xml · derivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,750 Underlying: Common Stock · 1,250 shares Expires 2025-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on March 20, 2015 and is exercisable as the option vests. The option vested over a 5 year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:05 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 1,250 | $235.00 | $293,750.00 |
DisclosureSEC source: 0000937556-20-000139 · wf-form4_159423872074184.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,465 F1 · kind: The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of May 21, 2020, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:05 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 1,250 | $31.01 | $38,762.50 |
DisclosureSEC source: 0000937556-20-000139 · wf-form4_159423872074184.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2020 Filed Apr 15, 2020 23:12 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $28.03 Strike: $28.03 | $56,060.00 |
DisclosureSEC source: 0000937556-20-000081 · wf-form4_158699233066079.xml · derivative · entry 9 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on February 18, 2014 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grantdate. Read SEC document |
| April 15, 2020 Filed Apr 15, 2020 23:12 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $28.03 Strike: $28.03 | $56,060.00 |
DisclosureSEC source: 0000937556-20-000081 · wf-form4_158699233066079.xml · derivative · entry 8 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on February 18, 2014 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grantdate. Read SEC document |
| April 15, 2020 Filed Apr 15, 2020 23:12 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 2,000 | $200.00 | $400,000.00 |
DisclosureSEC source: 0000937556-20-000081 · wf-form4_158699233066079.xml · nonDerivative · entry 6 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,465 F1 · kind: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of March 12, 2020, which is intended to comply with Rule 10b5-1 promulgated under the SecuritiesExchange Act of 1934, as amended. Read SEC document |
| April 15, 2020 Filed Apr 15, 2020 23:12 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $28.03 | $56,060.00 |
DisclosureSEC source: 0000937556-20-000081 · wf-form4_158699233066079.xml · nonDerivative · entry 5 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2020 Filed Apr 15, 2020 23:12 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 2,000 | $195.00 | $390,000.00 |
DisclosureSEC source: 0000937556-20-000081 · wf-form4_158699233066079.xml · nonDerivative · entry 4 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,465 F1 · kind: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of March 12, 2020, which is intended to comply with Rule 10b5-1 promulgated under the SecuritiesExchange Act of 1934, as amended. Read SEC document |
| April 15, 2020 Filed Apr 15, 2020 23:12 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $28.03 | $56,060.00 |
DisclosureSEC source: 0000937556-20-000081 · wf-form4_158699233066079.xml · nonDerivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 23:12 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $28.03 Strike: $28.03 | $56,060.00 |
DisclosureSEC source: 0000937556-20-000081 · wf-form4_158699233066079.xml · derivative · entry 7 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on February 18, 2014 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grantdate. Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 23:12 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 2,000 | $190.00 | $380,000.00 |
DisclosureSEC source: 0000937556-20-000081 · wf-form4_158699233066079.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,465 F1 · kind: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of March 12, 2020, which is intended to comply with Rule 10b5-1 promulgated under the SecuritiesExchange Act of 1934, as amended. Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 23:12 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $28.03 | $56,060.00 |
DisclosureSEC source: 0000937556-20-000081 · wf-form4_158699233066079.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 23:08 UTC | MASIMO CORP MASI · Entity 39014 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 4,422 | $179.42 Strike: $179.42 | $793,395.24 |
DisclosureSEC source: 0000937556-20-000044 · wf-form4_158440009402512.xml · derivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,422 Underlying: Common Stock · 4,422 shares Expires 2030-03-12 F1 · derivative.exercise_date: This option was granted on March 12, 2020 and is exercisable as the option vests. The option vests over a 5 year period, with 20% of the shares subject to the option vesting each year starting March 22, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:06 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionRestricted Stock Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-20-000002 · wf-form4_157834478699783.xml · derivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU. F2 · derivative.exercise_date: On February 27, 2018, the Reporting Person was granted 10,000 restricted stock units, 20% of which were vested upon grant and 20% of which will vest on the first business day of each fiscal year thereafter. F2 · derivative.expiration_date: On February 27, 2018, the Reporting Person was granted 10,000 restricted stock units, 20% of which were vested upon grant and 20% of which will vest on the first business day of each fiscal year thereafter. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:06 UTC | MASIMO CORP MASI · Entity 39014 | Tax withholdingCommon Stock | 736 | $158.58 | $116,714.88 |
DisclosureSEC source: 0000937556-20-000002 · wf-form4_157834478699783.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,465 Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:06 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-20-000002 · wf-form4_157834478699783.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:35 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $31.01 Strike: $31.01 | $62,020.00 |
DisclosureSEC source: 0000937556-19-000070 · wf-form4_155423730110686.xml · derivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 2,000 shares Expires 2025-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on March 20, 2015 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:35 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 2,000 | $140.00 | $280,000.00 |
DisclosureSEC source: 0000937556-19-000070 · wf-form4_155423730110686.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,201 F1 · kind: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 12, 2018, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:35 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $31.01 | $62,020.00 |
DisclosureSEC source: 0000937556-19-000070 · wf-form4_155423730110686.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:06 UTC | MASIMO CORP MASI · Entity 39014 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 7,235 | $133.50 Strike: $133.50 | $965,872.50 |
DisclosureSEC source: 0000937556-19-000052 · wf-form4_155302959572124.xml · derivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,235 Underlying: Common Stock · 7,235 shares Expires 2029-03-15 F1 · derivative.exercise_date: This option was granted on March 15, 2019 and is exercisable as the option vests. The option vests over a 5 year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 21:56 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $31.01 Strike: $31.01 | $62,020.00 |
DisclosureSEC source: 0000937556-19-000046 · wf-form4_155130455106623.xml · derivative · entry 6 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 2,000 shares Expires 2025-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on March 20, 2015 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 21:56 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 2,000 | $135.00 | $270,000.00 |
DisclosureSEC source: 0000937556-19-000046 · wf-form4_155130455106623.xml · nonDerivative · entry 4 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,201 F1 · kind: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 12, 2018, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 27, 2019 Filed Feb 27, 2019 21:56 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $31.01 | $62,020.00 |
DisclosureSEC source: 0000937556-19-000046 · wf-form4_155130455106623.xml · nonDerivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 21:56 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $31.01 Strike: $31.01 | $62,020.00 |
DisclosureSEC source: 0000937556-19-000046 · wf-form4_155130455106623.xml · derivative · entry 5 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 2,000 shares Expires 2025-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on March 20, 2015 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 21:56 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 2,000 | $130.00 | $260,000.00 |
DisclosureSEC source: 0000937556-19-000046 · wf-form4_155130455106623.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,201 F1 · kind: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 12, 2018, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 21:56 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $31.01 | $62,020.00 |
DisclosureSEC source: 0000937556-19-000046 · wf-form4_155130455106623.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 21:03 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $21.97 Strike: $21.97 | $43,940.00 |
DisclosureSEC source: 0000937556-19-000027 · wf-form4_154905498911142.xml · derivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2023-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on May 28, 2013 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 21:03 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 2,000 | $125.00 | $250,000.00 |
DisclosureSEC source: 0000937556-19-000027 · wf-form4_154905498911142.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,201 F1 · kind: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 12, 2018, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 31, 2019 Filed Feb 1, 2019 21:03 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $21.97 | $43,940.00 |
DisclosureSEC source: 0000937556-19-000027 · wf-form4_154905498911142.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2019 Filed Jan 22, 2019 21:09 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $21.97 Strike: $21.97 | $43,940.00 |
DisclosureSEC source: 0000937556-19-000025 · wf-form4_154819135988518.xml · derivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on May 28, 2013 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| January 18, 2019 Filed Jan 22, 2019 21:09 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 2,000 | $120.00 | $240,000.00 |
DisclosureSEC source: 0000937556-19-000025 · wf-form4_154819135988518.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,201 F1 · kind: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 12, 2018, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 18, 2019 Filed Jan 22, 2019 21:09 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $21.97 | $43,940.00 |
DisclosureSEC source: 0000937556-19-000025 · wf-form4_154819135988518.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:08 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $21.97 Strike: $21.97 | $43,940.00 |
DisclosureSEC source: 0000937556-19-000021 · wf-form4_154767287795709.xml · derivative · entry 3 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on May 28, 2013 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:08 UTC | MASIMO CORP MASI · Entity 39014 | SaleCommon Stock | 2,000 | $115.00 | $230,000.00 |
DisclosureSEC source: 0000937556-19-000021 · wf-form4_154767287795709.xml · nonDerivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,201 F1 · kind: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 12, 2018, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:08 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $21.97 | $43,940.00 |
DisclosureSEC source: 0000937556-19-000021 · wf-form4_154767287795709.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:16 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionRestricted Stock Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-19-000002 · wf-form4_154663659363109.xml · derivative · entry 2 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU. F2 · derivative.exercise_date: On February 27, 2018, the Reporting Person was granted 10,000 restricted stock units, 20% of which vested upon grant and 20% of which will vest on the first business day of each fiscal year thereafter. F2 · derivative.expiration_date: On February 27, 2018, the Reporting Person was granted 10,000 restricted stock units, 20% of which vested upon grant and 20% of which will vest on the first business day of each fiscal year thereafter. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:16 UTC | MASIMO CORP MASI · Entity 39014 | Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000937556-19-000002 · wf-form4_154663659363109.xml · nonDerivative · entry 1 Coleman Jon · CIK 0001442689 · Pres-WW Sales,Pro Svc,Med Affs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.